OmniComm Systems Signs Letter of Intent to Acquire Assets of Algorithm and its Algorics

November 21, 2017

Applied Clinical Trials

 

OmniComm Systems, Inc. and Algorithm, Inc. have signed a letter of intent, under which OmniComm will acquire assets and assume liabilities of Algorics to build upon RBM and data analytics. By combining forces, the companies expect increased operating efficiency, strengthened traction in the risk-based approach solution area, new marketing opportunities, an expanded portfolio of electronic data capture solutions for the clinical trials industry, and will provide OmniComm with access to advanced analytics and algorithms.

Read the full release here.

Related Content:

News